For Veterinarians

Dear Colleagues,
At Equinox Healthcare, we are committed to working closely with you to provide the best possible treatment for our mutual patients. We see our range of therapies as both a complement to and extension of your veterinary care. Therefore, we would like to stay in close contact with you even after the radiation therapy has been completed in order to support you in the aftercare, which is usually carried out by the referring vet.

Discuss a case?


...

The two main indications for radiation therapy are local tumours and chronic inflammatory diseases.

Neoplasms are treated with a high total dose, which is divided into several individual fractions. The protocols of the so-called benign radiation, which is used for arthroses and other chronically painful indications, consist of fewer fractions with significantly lower doses.
We also differentiate between curative and palliative radiation protocols. You are welcome to discuss with our veterinarians which protocol is suitable for the individual patient.

Equine Sarcoid

Equines Sarkoid
Equine sarcoids are the most common tumours in equines worldwide. They are caused by virus-induced degeneration of fibroblasts with various forms of proliferation. They rarely metastasize and are histologically classified as benign tumors. Surgical excision alone is often not sufficient because the tumours have enormous potential for recurrence. Their sometimes very large growth and often ulcerative character can lead to major local problems for the horses. Due to their clinical appearance, the tumours still often have to be classified as malignant.
The triggering viruses are the bovine papillomaviruses 1 and 2, which have adapted to horses over the years and are genetically different from the original cattle viruses. Until a few years ago, it was assumed that the infection in horses was abortive, i.e. that a horse as a “false host” could not infect other horses. However, immunohistological methods have shown that in many forms of sarcoids, intact viruses are emitted into the environment, thus proving there is a potential risk of infection from a horse with sarcoids. For BPV-1/-2 transmission to the next horse to lead to sarcoid formation, however, there must be injury to the epidermis to allow the virus to penetrate to the basal cell layer, and certain conditions must be met by the immune system of the new host.
In addition to surgery and the local application of ointments, which are frequently associated with relapses, radiation therapy is also available.

Squamous Cell Carcinoma (SCC)

Equinox

Equinox Healthcare GmbH
Strahlentherapiezentrum für Pferde und Kleintiere
An der Wann 8-10
63589 Linsengericht

T. +49(0) 6051 49098 – 10
F. +49(0) 6051 49098 – 11

www.equinox.vet